secwatch.observer — SEC 8-K summary
======================================

Issuer:     Paysign, Inc. (PAYS)
CIK:        0001496443
Form:       8-K
Filed at:   2022-05-11T23:59:59+00:00
Accession:  0001683168-22-003450
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Paysign Q1 revenue $8.2M (+31% YoY), net loss $0.3M; reaffirms FY2022 guidance
------------------------------------------------------------------------------

- Revenue $8.2M vs $6.3M in Q1 2021; net loss $0.3M (($0.01) per share).
- Plasma revenue up 37% to $7.4M; added 9 new centers, exiting with 375 total.
- Pharma revenue down 9% to $0.8M; launched 4 new copay programs during quarter.
- Adjusted EBITDA positive at $0.9M ($0.02/share) vs negative in Q1 2021.
- FY2022 outlook unchanged: revenue $35.25M-$38.35M, adj. EBITDA at least $4.0M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1496443/000168316822003450/0001683168-22-003450-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1496443/000168316822003450/paysign_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-003450

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer